Coal remains the country’s ‘main power source,’ battery king branches into offshore wind, German drugmaker inks green energy deal with China Resources Power

German drugmaker will buy 300 gigawatt-hours of electricity generated from renewable sources from China Resources Power over the next 10 years

American pharma giant pulls out of pact on two cancer treatments after signing $22 billion accord with Japan’s Daiichi Sankyo

Lagevrio, to be marketed in China by Sinopharm, cleared for mild and moderate infections among at-risk adults

Drugmakers consider technology transfer to crank up production once the treatment wins regulatory approval

The pill’s remarkably quick approval has set tongues wagging that it‘s a sign Beijing might be preparing to relax its strict pandemic controls

Fosun, BrightGene, Longze, Desano and Langhua agree to cooperate with U.N-backed group lining up generic production of coronavirus treatment

Treatment that could be taken at home at the first sign of symptoms could upend how the disease is treated and alter the course of the pandemic

Coming wave of Chinese therapies promise to dramatically cut costs, but gaining traction in the complex and opaque American health-care system will be tough

Green light shows drug regulator has recognized China’s urgent need for Gardasil 9

Gardasil 9 protects against more strains of sexually transmitted virus that can cause cancer

U.S. giant applies to sell Keytruda, joining global rival Bristol-Myers Squibb

U.K. drugmaker gets inoculation for key cause of cervical cancer to mainland ahead of Merck, which controlled 94% of market in 2016

Green light comes year after rival GlaxoSmithKline obtained approval of similar product in the country